Home > Healthcare > Medical Devices > Diagnostic Devices > Cardiac Arrhythmia Monitoring Devices Market
Cardiac Arrhythmia Monitoring Devices Market size surpassed USD 6.4 billion in 2021 and is anticipated to progress at 6.7% CAGR between 2022 and 2028. Rising prevalence of severe cardiovascular diseases across the globe will drive the market growth. According to the World Health Organization (WHO), cardiovascular diseases are responsible for around 17.9 million deaths, globally, each year.
Arrhythmic conditions such as tachycardia and bradycardia are more common in people with severe CVD and require continuous monitoring to avoid sudden heart failure. Thus, with increased prevalence of cardiac illnesses, the demand for cardiac arrhythmia monitoring devices is expected to grow significantly throughout the analysis period.
Report Attribute | Details |
---|---|
Base Year: | 2021 |
Cardiac Arrhythmia Monitoring Devices Market Size in 2021: | 6.5 Billion (USD) |
Forecast Period: | 2022 to 2028 |
Forecast Period 2022 to 2028 CAGR: | 6.7% |
2028 Value Projection: | 10.3 Billion (USD) |
Historical Data for: | 2017 to 2021 |
No. of Pages: | 150 |
Tables, Charts & Figures: | 229 |
Segments covered: | Device, Application, End-use and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The COVID 19 pandemic had moderate positive impact on adoption of cardiac arrhythmia monitoring devices in 2020. Further, with declining number COVID-19 patients and continuation of all healthcare services has influenced the product demand. Several healthcare companies are working collaboratively to expand manufacturing capacity of cardiac arrhythmia monitoring devices such as Holter monitors, patches, and wearable ECG among others to provide medical aid while keeping check on progress of the patients. Thus, with declining number of COVID-19 infection among population, the market will experience momentous growth in foreseeable future.
Cardiac arrhythmia monitoring devices are mainly used for monitoring patients with high risk of arrhythmic conditions. These devices help healthcare professionals in monitoring irregular heartbeat for better diagnosis and treatment of CVD patients to reduce associated mortalities.